In this episode, host Dr. Gregg Sherman and NACE expert faculty member, Lucia M. Novak, MSN, ANP-BC. BC-ADM, discuss Optimizing Outcomes in Diabetes With GLP-1 Therapy. Dr. Sherman and Ms. Novak discuss the glycemic and cardiorenal effects of GLP-1 RAs, the differences between injectable and oral GLP-1 RA formulations, and strategies for integrating GLP-1 RA therapy into earlier therapeutic decision-making, based on the newest treatment.
About Lucia M. Novak, MSN, ANP-BC. BC-ADM
President and Owner, Diabetes Consulting Services, Rockville, MD
Diabetes Expert, Diabetes & Endocrine Associates, Silver Spring, MD
Ms. Novak is a board-certified nurse practitioner in both Adult Health and Advanced Diabetes Management and has over 17 years of clinical, research and educational experience in diabetes mellitus. Ms. Novak has provided her expertise pertaining to diabetes as a Contributing Author for the Lippincott Manual of Nursing Practice for the last 4 editions and is also a Contributing Author for the 1st edition of Genomic Essentials for Graduate Level Nurses. Ms. Novak serves as an Associate Editor for Clinical Diabetes.
Ms. Novak has been repeatedly recognized for her outstanding contributions as a clinician, researcher and educator. In 2015, she was designated Master Clinician for her proven leadership and clinical prowess, an accolade that placed her among the top 2% of the health care providers of the Walter Reed National Military Medical Center and is also a recipient of The DAISY Foundation Award for Extraordinary Nurses.
Her nearly 28 years of nursing experience include active duty service as a Commissioned Officer of the United States Army Nurse Corps.
This podcast episode is supported by an independent medical education grant from Novo Nordisk. This activity is not certified for CME/CE credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
In this episode, host Dr. Gregg Sherman and NACE expert faculty member, Lucia M. Novak, MSN, ANP-BC. BC-ADM, discuss Optimizing Outcomes in Diabetes With GLP-1 Therapy. Dr. Sherman and Ms. Novak discuss the glycemic and cardiorenal effects of GLP-1 RAs, the differences between injectable and oral GLP-1 RA formulations, and strategies for integrating GLP-1 RA therapy into earlier therapeutic decision-making, based on the newest treatment.
About Lucia M. Novak, MSN, ANP-BC. BC-ADM
President and Owner, Diabetes Consulting Services, Rockville, MD
Diabetes Expert, Diabetes & Endocrine Associates, Silver Spring, MD
Ms. Novak is a board-certified nurse practitioner in both Adult Health and Advanced Diabetes Management and has over 17 years of clinical, research and educational experience in diabetes mellitus. Ms. Novak has provided her expertise pertaining to diabetes as a Contributing Author for the Lippincott Manual of Nursing Practice for the last 4 editions and is also a Contributing Author for the 1st edition of Genomic Essentials for Graduate Level Nurses. Ms. Novak serves as an Associate Editor for Clinical Diabetes.
Ms. Novak has been repeatedly recognized for her outstanding contributions as a clinician, researcher and educator. In 2015, she was designated Master Clinician for her proven leadership and clinical prowess, an accolade that placed her among the top 2% of the health care providers of the Walter Reed National Military Medical Center and is also a recipient of The DAISY Foundation Award for Extraordinary Nurses.
Her nearly 28 years of nursing experience include active duty service as a Commissioned Officer of the United States Army Nurse Corps.
This podcast episode is supported by an independent medical education grant from Novo Nordisk. This activity is not certified for CME/CE credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.